Form 8-K - Groowe Newsroom

8-K — BiomX Inc.

Accession: 0001213900-26-035605

Filed: 2026-03-27

Period: 2026-03-25

CIK: 0001739174

SIC: 2836 (BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES))

Item: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — ea0283776-8k_biomx.htm (Primary)

EX-99.1 — PRESS RELEASE DATED MARCH 27, 2026 (ea028377601ex99-1_biomx.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0283776-8k_biomx.htm · Sequence: 1

false

0001739174

2026-03-25

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

March 25, 2026

BIOMX

INC.

(Exact name of registrant as specified in its charter)

Delaware

001-3876

82-3364020

(State or other jurisdiction of

incorporation or organization)

(Commission File Number)

(IRS Employer

Identification Number)

850

New Burton Road, Suite 201, Dover,

DE 19904

(Address of principal executive offices)

972

52 437 4900

(Registrant’s telephone number, including

area code)

Not Applicable

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

PHGE

NYSE American

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to

Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Continued Listing Standards

On March 25, 2026, BiomX, Inc, a Delaware corporation (the “Company”), received a written notice (the “Notice”)

from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued

listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company

to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in

two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders’ equity

of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal

years and Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders’ equity at least $6.0 million if it

has reported losses from continuing operations and/or net losses in its five most recent fiscal years. The Notice also indicates that

the Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide (including the exemption provided

for companies with total value of market capitalization exceeding $50 million among other things).

In connection with its non-compliance with Section 1003(a)(i), Section 1003(a)(ii) and Section 1003(a)(iii), the Company must submit a

plan (the “Plan”) to the NYSE American by April 24, 2026, advising of actions it has taken or will take to regain compliance

with the continued listing standards by September 25, 2027. If the NYSE American determines to accept the Plan, the Company will be notified

in writing and will be subject to periodic reviews, including quarterly monitoring for compliance with the Plan. If the Company does not

submit a plan or if the Plan is not accepted, NYSE American will commence delisting proceedings. Furthermore, if the Plan is accepted

but the Company is not in compliance with the continued listing standards by September 25, 2027, or if the Company does not make progress

consistent with the Plan, the NYSE American will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting

determination in accordance with Section 1010 and Part 12 of the Company Guide.

The Notice has no immediate effect on the listing or trading

of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and the Common Stock will continue to trade

on the NYSE American under the symbol “PHGE.”

The Company’s receipt of the Notice does not affect the Company’s

business, operations or reporting requirements with the Securities and Exchange Commission. The Company’s management is reviewing

its options to address the deficiencies and expects to submit a compliance plan on or before the deadline set by the NYSE American.

Item 8.01

Other Events.

On March 27, 2026, the Company issued a press release discussing the matters disclosed in Item 3.01 above. A copy of the press release

is attached herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Description

99.1

Press release dated March 27, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

BIOMX INC.

Date: March 27, 2026

By:

/s/ Michael Oster

Name:

Michael Oster

Title:

Chief Executive Officer

EX-99.1 — PRESS RELEASE DATED MARCH 27, 2026

EX-99.1

Filename: ea028377601ex99-1_biomx.htm · Sequence: 2

Exhibit 99.1

BiomX Inc. Received NYSE American Notification

Letter Regarding Stockholders' Equity Deficiency

Discloses “Going Concern” Explanatory

Paragraph in Auditor’s Report

Netanya, Israel - March 27, 2026 –

BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that on March 25, 2026,

the Company received a notice from the staff of NYSE American LLC (the “NYSE American”) that the Company was not in compliance

with the NYSE American’s continued listing standards in Part 10, Section 1003(a)(i), (ii), and (iii)of the NYSE American Company

Guide (the “Company Guide”), requiring a company to have stockholders’ equity of at least $2.0 million if it has reported

losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide

requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or

net losses in three of its four most recent fiscal years and Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders’

equity at least $6.0 million if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years.

The Notice also indicates that the Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide (including

the exemption provided for companies with total value of market capitalization exceeding $50 million among other things).

In connection with its non-compliance with Section

1003(a)(i), Section 1003(a)(ii) and Section 1003(a)(iii), the Company must submit a plan (the “Plan”) to the NYSE American

by April 24, 2026, advising of actions it has taken or will take to regain compliance with the continued listing standards by September

25, 2027. If the NYSE American determines to accept the Plan, the Company will be notified in writing and will be subject to periodic

reviews, including quarterly monitoring for compliance with the Plan. If the Company does not submit a plan or if the Plan is not accepted,

NYSE American will commence delisting proceedings. Furthermore, if the Plan is accepted but the Company is not in compliance with the

continued listing standards by September 25, 2027, or if the Company does not make progress consistent with the Plan, the NYSE American

will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting determination in accordance with Section

1010 and Part 12 of the Company Guide.

The Notice has no immediate effect on the listing

or trading of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and the Common Stock will continue

to trade on the NYSE American under the symbol “PHGE.”

The Company’s receipt of the Notice does

not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission. The Company’s

management is reviewing its options to address the deficiencies and expects to submit a compliance plan on or before the deadline set

by the NYSE American.

Additionally, as previously disclosed in its annual

report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the Securities and Exchange Commission on February

19, 2026, the audit opinion contained a going concern qualification from the Company's independent registered public accounting firm.

This announcement is being made solely to comply with the Company Guide Sections 401(h) and 610(b), which require separate disclosure

of receipt of an audit opinion that contains a going concern qualification. This announcement does not represent any change or amendment

to the Company's 2025 audited financial statements or to its 2025 Annual Report on Form 10-K.

Forward Looking Statements

This press release contains forward-looking statements

within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,”

“continue,” “anticipate,” “intend,” “should,” “plan,” “could,”

“target,” “potential,” “is likely,” “will,” “expect” and similar expressions,

as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely

on our current expectations and projections about future events and financial trends that we believe may affect our financial condition,

results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements

may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking

statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ

may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update

any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by

law.

Investor & Media Contact

Yair Ohayon

Yairo@biomx.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Mar. 25, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Mar. 25, 2026

Entity File Number

001-3876

Entity Registrant Name

BIOMX

INC.

Entity Central Index Key

0001739174

Entity Tax Identification Number

82-3364020

Entity Incorporation, State or Country Code

Entity Address, Address Line One

850

New Burton Road

Entity Address, Address Line Two

Suite 201

Entity Address, City or Town

Dover

Entity Address, State or Province

Entity Address, Postal Zip Code

19904

City Area Code

972

Local Phone Number

52 437 4900

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.0001 par value per share

Trading Symbol

PHGE

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration